Screener
Lexicon Pharmaceuticals LXRX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.07B.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
FAQ
- What is Lexicon Pharmaceuticals's market capitalization?
- Lexicon Pharmaceuticals (LXRX) reported market capitalization of $1.07B in Q2 2026.
- How has Lexicon Pharmaceuticals's market capitalization changed year-over-year?
- Lexicon Pharmaceuticals's market capitalization increased by 281.1% year-over-year, from $279.76M to $1.07B.
- What is the long-term trend for Lexicon Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's market capitalization has grown at a -3.9% compound annual growth rate (CAGR), from $509.22M to $417.91M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Lexicon Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude